Cullinan Therapeutics, Inc. (CGEM)
NASDAQ: CGEM · Real-Time Price · USD
7.91
+0.37 (4.91%)
At close: May 12, 2025, 4:00 PM
7.91
0.00 (0.00%)
After-hours: May 12, 2025, 4:05 PM EDT
Cullinan Therapeutics Market Cap
Cullinan Therapeutics has a market cap or net worth of $466.81 million as of May 12, 2025. Its market cap has decreased by -42.62% in one year.
Market Cap
466.81M
Enterprise Value
164.82M
1-Year Change
-42.62%
Ranking
Category
Stock Price
$7.91
Market Cap Chart
Since the IPO on January 8, 2021, Cullinan Therapeutics's market cap has decreased from $829.45M to $466.81M, a decrease of -43.72%. That is a compound annual growth rate of -12.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 444.97M | -37.26% |
| Dec 31, 2024 | 709.21M | 62.69% |
| Dec 29, 2023 | 435.93M | -9.73% |
| Dec 30, 2022 | 482.90M | -28.36% |
| Dec 31, 2021 | 674.05M | -18.74% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.30B |
| Johnson & Johnson | 370.87B |
| UnitedHealth Group | 343.58B |
| AbbVie | 335.74B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 229.64B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |